Planned sale of 171,750 AVAH shares disclosed in Form 144 filing
Rhea-AI Filing Summary
An affiliated holder of AVAH common stock plans to sell 171,750 shares, with an aggregate market value of 1,361,978.00, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/19/2026.
The securities relate to restricted stock vesting on 02/14/2026, when 425,304 shares of common stock were acquired from the issuer. Over the prior three months, the same account sold 50,970 shares of common stock for gross proceeds of 413,942.66.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What recent AVAH stock sale activity is disclosed in this Form 144?
The notice reports a prior sale of 50,970 shares of AVAH common stock. That transaction occurred on 01/02/2026 and generated gross proceeds of 413,942.66, providing context for recent selling activity from the same account over the past three months.
What representation does the AVAH insider make about nonpublic information?
By signing the notice, the selling person represents they do not know any material adverse information about AVAH’s current or prospective operations that has not been publicly disclosed, as required in the standard Rule 144 Form 144 representation language included in the document.
What is the approximate timing of the AVAH stock sale under this notice?
The approximate date of sale for the 171,750 AVAH common shares is listed as 02/19/2026. This timing applies to the proposed NASDAQ transaction handled through Morgan Stanley Smith Barney, as disclosed in the securities information section of the notice.